Related Experiment Video
Updated: May 31, 2026

Knockdown of FAM83A to Verify Its Role in Cervical Cancer Cell Growth and Cisplatin Sensitivity
Published on: February 9, 2024
Association between cytokine gene polymorphisms and cervical cancer in a Chinese population
Qian Wang1, Chenhua Zhang, Shah Walayat
1Centre for Cancer Research, First Affiliated Hospital, Xi'an Jiaotong University, Xi'an, Shaanxi 710061, China.
Objectives:
It has been hypothesized that inherited cytokine gene polymorphisms could influence susceptibility to cervical cancer. This study evaluated the association between tumour necrosis factor-alpha (TNF-α)-308, transforming growth factor-beta 1 (TGF-β1), interferon-gamma (IFN-γ)+874 and interleukin-10 (IL-10)-1082 gene polymorphisms and cervical cancer risk.
Study Design:
The study population included 186 histopathologically confirmed cases of cervical cancer and 200 healthy controls. TNF-α, TGF-β, IL-10 and IFN-γ gene polymorphisms were genotyped by polymerase chain reaction with sequence-specific primers.
Results:
The IFN-γ+874A/A genotype was associated with high risk for the development of cervical cancer [odds ratio (OR) 2.22, p=0.012], and the A allele was associated with a 1.47-fold increased risk of cervical cancer (p=0.009). In contrast, no significant difference was found in the frequencies of TNF-α-308G/A, TGF-β1 codons 10 and 25 C/C-G/G and IL-10-1082G/A gene polymorphisms between patients with cervical cancer and healthy controls.
Conclusions:
Homozygous IFN-γ+874A/T polymorphisms may be associated with increased risk for the development of cervical cancer.
Related Concept Videos
Single Nucleotide Polymorphisms-SNPs
Cancer Prevention
Some...
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Comparing Copy Number Variations and SNPs
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...

